Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial
Top Cited Papers
- 13 April 2012
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 13 (6), 579-588
- https://doi.org/10.1016/s1470-2045(12)70116-x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Correlation of capecitabine-induced skin toxicity with treatment efficacy in patients with metastatic colorectal cancer: results from the German AIO KRK-0104 trialBritish Journal of Cancer, 2011
- Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III TrialJournal of Clinical Oncology, 2011
- Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2Journal of Clinical Oncology, 2010
- Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trialThe Lancet, 2009
- Methods for Equivalence and Noninferiority TestingTransplantation and Cellular Therapy, 2009
- Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal CancerJournal of Clinical Oncology, 2008
- Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203Journal of Clinical Oncology, 2006
- The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: how successful have we been?Annals of Oncology, 2006
- Impact of a surgical training programme on rectal cancer outcomes in StockholmBritish Journal of Surgery, 2004
- Statistics in Medicine: Calculating confidence intervals for survival time analysesBMJ, 1988